A simple technique to gauge brain levels of a toxic protein could improve diagnosis and drug trials, to help in the quest to diagnose and treat Alzheimer’s disease.
A drug developed for type 2 diabetes has “significantly reversed memory loss” in mice with Alzheimer’s disease, and researchers now want to test it on humans.
Scientists have identified differences in a group of genes they say might help explain why some people need a lot more sleep, and others less, than most.
An adapted CRISPR technique could be used to treat incurable diseases, such as diabetes and muscular dystrophy, by turning up the volume on selected genes.
Using ‘Raman’ optical technology, scientists can now produce images of brain tissue that is affected by Alzheimer’s disease.
A type of abnormal protein thought to be the cause of Creutzfeldt-Jakob has been found in the skin of 23 patients who died from the disease
One under the radar biotech could be trumping all its competitors, after it makes significant progress in potentially producing an Alzheimer’s treatment.
A team of scientists have discovered that an Indiana Amish community hold the key to living 10% longer, all thanks to a copy of a genetic mutation.
Bill Gates has revealed plans to personally invest $100 million in the Dementia Discovery Fund (DDF), with the hopes of finding new treatments.
35 years of twin research has enabled us to increase our insights into how the environment and our genes impact our health.
The science of ageing has made a lot of progress recently. Here are three examples of discoveries that might benefit people who are alive right now.